Use cases
The analysis that has waited for weeks, as a draft you can check.
Typical workflows from route planning to shelf life, each with a result your expert reviews and approves. Plus computed examples with input, tool and date.
Create an account, get your API key, use the tools in your usual working environment.
From target molecule to salt form.
A route to the target molecule
A new target molecule has no reliable route yet. CovaSyn lays out alternative routes down to purchasable building blocks, every structure chemically checked, and flags intermediates with ICH M7 structural alerts. Your chemists start with a justified shortlist and a ready order list.
Plan an ICH stability study
The accelerated data is in, and the shelf-life question is on the table. CovaSyn drafts the study plan under ICH Q1A, fits the Arrhenius model and calculates shelf life with a confidence bound. You go into the QA discussion with a justified shelf life.
Docking screen
A long candidate list needs to shrink to a few hits. CovaSyn docks the structures from your SMILES list and ranks the hits by docking score and synthesisability. Only candidates that bring both go to the lab.
Formulation optimisation with DoE
The formulation works, but nobody knows exactly why, and every change is a risk. CovaSyn proposes an RSM design, plans the runs, fits the model and checks robustness. You receive a recommendation with the range in which the formulation runs safely.
Antibody stability profile
An antibody candidate needs an early check for developability risks. From the sequence, CovaSyn calculates hydrophobic patches, aggregation risk, isoelectric point and viscosity hotspots. You know the weak spots before the first formulation.
Solubility screen for salt selection
The API is poorly soluble, and the salt screen should not start with a long candidate list. CovaSyn calculates pH-dependent solubility curves and evaluates antisolvent strategies and solvent mixtures. Your screen starts with the salt forms most likely to work.
Independently measured.
- Without CovaSyn
- 14 to 41%
- With CovaSyn
- 76 to 92%
Computed examples from drug development.
Every page carries a real result computed with our own tools, with input, tool name and run date. Technically reviewed before it appears.
ICH M7 pre-screening of nitrosamine impurities: what the class actually tells you
Four computed ICH M7 classifications, including the case where the structural alert and the statistical model disagree. With TTC threshold, mechanism, and what the class means for your next decision.
Source-verified, 2026-08-03
See the calculationMolecular formula from exact mass: why 5 ppm is often not enough
Two computed examples show the difference between an unambiguous and an ambiguous assignment. With mass error in ppm, RDBE, and the question of which candidate formula you may discard.
Source-verified, 2026-08-04
See the calculationPredicting 1H shifts before you measure: what the confidence interval tells you
Nine computed 1H shifts for paracetamol, each with a confidence interval. Why the width of the interval matters more for planning than the predicted value.
Source-verified, 2026-08-04
See the calculationPlanning an ICH Q1A stability study: 33 determinations for a 24-month shelf life
A computed study plan for climatic zone II with conditions, timepoints and sample count. What the number 33 means for your lab planning and where it still changes.
Source-verified, 2026-08-03
See the calculationHPLC starting method for an acidic compound: which gradient, and why TFA
A computed method proposal for ibuprofen with column, eluents, gradient and predicted retention time. Which parts are a starting point, and which you will adjust at the instrument anyway.
Source-verified, 2026-08-03
See the calculation
Looking for your role?
Head of Analytical / QC
Spectra and purity questions pile up, and releases wait.
Learn moreCMC and formulation
Stability packages and shelf-life estimates take days, and DoE lives in Excel.
Learn moreQA and regulatory
ICH M7 assessments take weeks, and there is no quick first read on nitrosamine risk.
Learn more
Frequently asked questions
Which use case is the best starting point?
For CDMOs and pharma CMC teams, ICH stability studies are the fastest entry: defined outputs and clear audit requirements. For medicinal chemistry and drug discovery: retrosynthesis or docking. For formulation teams: DoE. It makes sense to start with one use case and then expand.
How do I integrate CovaSyn into our working environment?
Add one entry to your application's configuration, paste your API key from the CovaSyn dashboard, done, no code. Example configurations for Claude Desktop, Cursor, VS Code and Python are MIT-licensed on GitHub (covasyn-mcp-examples).
My use case is not listed. What now?
The examples come from discovery and CMC. Our tools cover discovery, analytics and CMC, from NMR and MS to stability and toxicology, so usually something fits. Describe your workflow in the form below; if you leave your email address, we come back with a concrete proposal.
Can confidential projects run in your own data centre?
Yes. If your IT security or compliance rules out external hosting, the MCP server runs as a container on your infrastructure, behind your firewall, and your data does not go to CovaSyn. We set this up as an Expert Service: Systems. We clarify the details in an initial call.
What does the audit trail for ICH M7 and ICH Q1 workflows look like?
Every call is recorded with its tool version, configuration and timestamp, without permanently storing your inputs and results. That keeps every result reproducible.
Tool missing?
Tool not listed, or could not find a fit?
Tell us briefly what you need. If we have it, we send you the link. If we do not, we check whether we can add it, and you are the first to hear.
Email is optional. By entering it, you consent to us replying to your request; the data is used only for that reply.
Next step
Try the first workflow on your own structures.
Create an account, get your API key, use the tools in your usual working environment.